An acute drug shortage in the US and stable pricing along with product launches are likely to boost revenues of India’s pharmaceutical companies during the first quarter of this financial......
10 non-bank and non-finance stocks from the BSE500 Index universe that offer an optimal blend of low valuation, reasonably robust revenue and earnings growth in recent quarters, a strong balance......
A city pharma company has filed a criminal complaint about 'theft' of some of its technologies by a senior executive responsible for technology management of its products. The executive quit the......
Analysts attribute this outperformance to the government's proactive economic reform measures Illustration: Uttam Ghosh/Rediff.com Mid-and small-cap indices have outperformed large-caps in the......
Services attracted the most FDI during the first eleven months period of 2015-16. Foreign direct investment (FDI) in India increased to $37.53 billion during April-February period of the last......